Godlike Productions - Reply to Thread

Users Online Now: 1,728 (Who's On?)	Visitors Today: 791,406
Pageviews Today: 1,355,030	Threads Today: 527	Posts Today: 9,682
03:08 PM

REPLY TO THREAD

Subject Study: Because of reasons, whole truth omitted in communication about vaccine efficacy and effectiveness

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

[quote:Dataskrekk:MV80NzcwODk2Xzg2OTQ5MjcyXzVEODM1ODc1]
Vaccine efficacy and effectiveness is to be [b]weighted against risk[/b].
What they are currently doing with the new Covid vaccines (experimental treatment) is implying high effectiveness. Which is a fat lie (see above, they use tricks and have no sufficient data, exactly what also Bhakdi was saying).
When Fauci and others say "highly effective", they are either not informed or they lie. Fauci is a doctor (AFAIK), politiciens might just be uninformed about these facts.

When looking into different age groups, this lie becomes even more disgusting.
Younger people have not been very much at risk from Covid-19, it really might NOT be worth for these groups taking the risk of severe side-effects (including death e.g. due to blood clots) in order to prevent mild disease.

Compromised communication via the media and lacking data are no basis for these groups to reach informed consent. People are currently basically tricked into taking great risks.
[/quote]

Original Message FYI:
OVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
[link to www.thelancet.com (secure)]

"There are many lessons to learn from the way studies are conducted and results are presented. With the use of only RRRs, and omitting ARRs, reporting bias is introduced, which affects the interpretation of vaccine efficacy.10"

"Unfortunately, comparing vaccines on the basis of currently available trial (interim) data is made even more difficult by disparate study protocols, including primary endpoints (such as what is considered a COVID-19 case, and when is this assessed), types of placebo, study populations, background risks of COVID-19 during the study, duration of exposure, and different definitions of populations for analyses both within and between studies, as well as definitions of endpoints and statistical methods for efficacy. Importantly, we are left with the unanswered question as to whether a vaccine with a given efficacy in the study population will have the same efficacy in another population with different levels of background risk of COVID-19."

Very much in line with what Prof. Bhakdi is saying about claims regarding efficacy and effectiveness:
"Uncoordinated phase 3 trials do not satisfy public health requirements; platform trials designed to address public health relevant questions with a common protocol will allow decisions to be made, informed by common criteria and uniform assessment. These considerations on efficacy and effectiveness are based on studies measuring prevention of mild to moderate COVID-19 infection; they were not designed to conclude on prevention of hospitalisation, severe disease, or death, or on prevention of infection and transmission potential."

Pictures (click to insert)





\| Next Page >>